Group 1 - The legal opinion letter is issued by Shanghai Jintiancheng Law Firm regarding the 2024 Restricted Stock Incentive Plan of Anji Microelectronics Technology (Shanghai) Co., Ltd. [1][2] - The plan has received necessary approvals and authorizations from the company's board and supervisory board, confirming compliance with relevant laws and regulations [4][6][9]. - The first vesting period for the restricted stock is defined as from June 23, 2025, to June 18, 2026, following the grant date of June 20, 2024 [9][10]. Group 2 - The adjustment of the grant price and quantity of restricted stocks is based on the company's profit distribution plan, which includes a cash dividend of 4.50 yuan per 10 shares and a capital reserve increase of 3 shares for every 10 shares [7][8]. - The adjusted grant price is calculated to be approximately 42.16 yuan per share, while the adjusted quantity of restricted stocks is approximately 329,115 shares [8][9]. - The vesting conditions for the first period have been met, including the absence of adverse audit opinions and the fulfillment of performance targets [10][12]. Group 3 - A total of 7,504 shares of restricted stock will be canceled due to two incentive targets leaving the company, and an additional 139 shares will be canceled due to performance evaluations [13]. - The legal opinion concludes that the adjustments, vesting conditions, and cancellations comply with the relevant laws and regulations, confirming the legality and effectiveness of the incentive plan [13][14].

Core Viewpoint - The announcement details the results of the third vesting period of the 2022 Restricted Stock Incentive Plan and the second vesting period of the reserved portion, with a total of 648,570 shares set to be listed for trading on July 8, 2025 [1][15]. Summary by Sections Important Content Highlights - The total number of shares for this stock listing is 648,570, which is part of the equity incentive shares [1]. - The vesting registration for the third vesting period and the reserved portion's second vesting period was completed on June 30, 2025 [1]. Decision-Making Process and Disclosure - The board of directors approved the incentive plan on January 26, 2022, with independent directors and legal advisors providing their consent [2][5]. - The proposed list of incentive recipients was publicly disclosed from January 27 to February 5, 2022, with no objections received [3]. - The shareholders approved the incentive plan at a meeting on February 15, 2022 [4]. Vesting Details - For the first grant portion, 84 individuals received a total of 480,868 shares, representing 39.92% of the total granted shares [10]. - The reserved portion had 20 individuals eligible for 167,702 shares, with 50% of the reserved shares vesting [11][13]. Stock Listing and Capital Changes - The total share capital increased from 210,961,003 to 211,609,573 shares due to this vesting [14]. - The company received a total of RMB 25,553,658.00 from the incentive recipients, contributing to an increase in share capital and capital reserves [15]. Financial Impact - The basic earnings per share for Q1 2025 will be diluted due to the increase in total shares, with the net profit for the period reported at RMB 62,384,400.02 [15].

Core Viewpoint - Foxconn Industrial Internet Co., Ltd. has reported on the stock option and restricted stock incentive plan for 2019, detailing the exercise of stock options and the status of shares as of the second quarter of 2025. Group 1: Stock Option Exercise Details - The number of stock options exercisable in the fifth exercise period of the 2019 incentive plan is 13,265 shares, representing 0.39% of the total exercisable options for that period. As of April 30, 2025, a total of 3,242,376 shares have been exercised, accounting for 94.49% of the total options available for exercise in that period [1][16]. - For the portion of reserved stock options in the fifth exercise period, 46,960 options are available, with 1,680 shares exercised in the second quarter of 2025, which is 3.58% of the total options for that period [1][16]. - The remaining reserved stock options in the fifth exercise period total 941,750, with 587,374 shares exercised, representing 62.37% of the total options available for that period [1][16]. Group 2: Decision-Making and Disclosure Process - The decision-making process for the stock option exercise involved multiple meetings where independent directors and the supervisory board provided their opinions and legal advice was obtained from Beijing King & Wood Mallesons [1][16]. - The company has disclosed relevant information regarding the stock option and restricted stock incentive plan through the Shanghai Stock Exchange and other designated media [1][16]. Group 3: Impact on Financials and Share Structure - The total funds raised from this incentive plan amount to 5,927,421.28 yuan, which will be used to supplement the company's working capital [1][17]. - The exercise of stock options will result in an increase of 602,319 shares in the company's total share count, bringing the total to 19,859,465,126 shares, with no change in the controlling shareholder [1][17].

证券代码：300953 证券简称：震裕科技 公告编号：2025-078 宁波震裕科技股份有限公司 关于向 2024 年限制性股票激励计划 激励对象授予预留部分限制性股票的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示： ? 限制性股票预留授予日：2025 年 7 月 2 日 ? 限制性股票预留授予数量（调整后）：70.00 万股，占公司股本总额 ? 限制性股票授予价格（调整后）：19.50 元/股 ? 股权激励方式：第二类限制性股票 根据《宁波震裕科技股份有限公司 2024 年限制性股票激励计划（草案）》 （以下简称"《激励计划》"或"本激励计划"）规定的公司 2024 年限制性股 票预留授予条件已经成就，根据宁波震裕科技股份有限公司（以下简称"公司"） 会第七次会议、第五届监事会第五次会议，审议通过了《关于向 2024 年限制性 股票激励计划激励对象授予预留部分限制性股票的议案》，确定以 2025 年 7 月 二类限制性股票。现将有关事项说明如下： 一、2024 年限制性股票激励计划简述 （一）标的股票来源 本计划所涉及的第二类限制性股票 ...

Core Viewpoint - The company has reviewed and approved the list of reserved grant recipients for the 2024 restricted stock incentive plan, ensuring compliance with relevant laws and regulations [1][2]. Group 1: Compliance and Eligibility - The reserved grant recipients do not fall under any disqualifying conditions as per the Management Measures and Listing Rules [1]. - The recipients include company directors, senior management, core technical personnel, and other key management staff, all of whom are employed by the company and have signed relevant contracts [1][2]. - Independent directors, supervisors, foreign employees, and shareholders or actual controllers holding more than 5% of the company's shares are excluded from the incentive plan [1]. Group 2: Plan Details - The reserved grant recipients meet the qualifications stipulated in the Company Law, Securities Law, and other relevant regulations, confirming their eligibility for the incentive plan [2]. - The list of reserved grant recipients aligns with the recipients approved at the company's third extraordinary general meeting for the 2024 restricted stock incentive plan [2]. - The company plans to reserve 700,000 shares of the second category of restricted stock for 11 eligible recipients, with the reserved grant date set for July 2, 2025 [2].

Core Viewpoint - The announcement details the expiration of reserved rights under the 2024 Restricted Stock Incentive Plan due to the failure to identify incentive targets within the stipulated timeframe [1][3]. Group 1: Approval Process - The 2024 Restricted Stock Incentive Plan has undergone necessary approval procedures, including resolutions passed by the Supervisory Board and the Board of Directors [2]. - The plan was publicly disclosed, and no objections were raised during the public notice period [1][2]. Group 2: Reserved Rights Status - According to the regulations, the reserved grant portion must identify incentive targets within 12 months post-approval; otherwise, the reserved rights will expire [3]. - As of the announcement date, 335,000 shares of the second category of restricted stock have had their reserved rights expire due to the failure to identify incentive targets within the required timeframe [3]. Group 3: Impact of Expiration - The expiration of these reserved rights will not affect the company's capital structure, financial status, or operational results significantly [3]. - The management team is expected to continue fulfilling their responsibilities to create value for all shareholders [3].

Group 1 - The company held its third independent director meeting on July 2, 2025, with all three independent directors present, confirming the legality and validity of the meeting procedures [1][2] - The meeting approved the proposal regarding the conditions for the second exercise period of stock options and the lifting of restrictions on the second lock-up period for restricted stock under the 2023 stock option and restricted stock incentive plan [1][2] - The independent directors agreed to submit the proposal to the board of directors for further review [1][2] Group 2 - The meeting also approved the proposal to cancel a portion of stock options under the 2023 stock option and restricted stock incentive plan due to reasons such as employee resignation, death, performance assessment results, and expiration without exercise [2] - The cancellation process was deemed legal and compliant with relevant regulations, ensuring no harm to the company or its shareholders [2] - This proposal will also be submitted to the board of directors for consideration [2]

Group 1 - The company issued 11.4 million convertible bonds on August 10, 2023, raising a total of RMB 1.14 billion, with a net amount of RMB 1.1329132 billion after deducting issuance costs [1] - The convertible bonds, named "Aoweizhuan," began trading on the Shanghai Stock Exchange on September 1, 2023 [2] - The initial conversion price for the bonds was set at RMB 180.90 per share, which was later adjusted to RMB 180.74 per share starting November 2, 2023 [2] Group 2 - As of June 30, 2025, a total of RMB 50,000 worth of bonds had been converted into 487 shares, representing 0.000154% of the company's total shares before conversion [4] - The total amount of unconverted bonds as of June 30, 2025, was RMB 1,139,950,000, accounting for 99.995614% of the total issuance [4] - The company's total share capital increased to 315,637,856 shares after the conversion and other adjustments [8]

Core Viewpoint - The legal opinion letter confirms that Grandway Law Offices has conducted a thorough review of the procedures and compliance related to the repurchase and cancellation of certain restricted stocks by Jack Technology Co., Ltd. under its 2023 stock incentive plan, affirming that all actions taken are in accordance with relevant laws and regulations [1][6]. Summary by Sections Legal Basis and Procedures - The legal opinion is based on various laws and regulations, including the Company Law and Securities Law, ensuring that the procedures for the repurchase and cancellation of restricted stocks have been properly followed [1][2]. - The company has completed the necessary procedures for the repurchase and cancellation of restricted stocks, as outlined in the relevant management regulations and the stock incentive plan [3][4]. Reasons for Repurchase - The repurchase of restricted stocks is justified as one of the incentive recipients has left the company for personal reasons, and thus the company is entitled to repurchase the unvested restricted stocks [4][5]. - The stock incentive plan stipulates that if an incentive recipient's contract expires or they leave voluntarily or involuntarily without performance issues, the unvested restricted stocks cannot be released and must be repurchased by the company at the grant price [4][6]. Quantity and Price of Repurchase - The total number of restricted stocks to be repurchased is 18,600 shares, with the repurchase price adjusted to 9.82 yuan per share [5][6]. - The repurchase price is subject to adjustments based on company actions such as dividend distributions, ensuring compliance with the stock incentive plan [4][5].

[Table_Info1] 英科医疗(300677) 医药生物 [Table_Date] 发布时间：2025-07-02 [Table_Title] 证券研究报告 / 公司点评报告 推出限制性股票激励计划，彰显未来发展信心 [Table_Summary] 事件： 公司公告 2025 年限制性股票激励计划，6 月 20 日已向 1090 名激励对 象授予 1324.31 万股限制性股票，约占公告时总股本的 3.94%，授予价 格为 11.30 元/股。公司层面业绩考核目标值为，2026-2029 年公司营业 收入分别不低于 112.60/ 122.80/ 132.80/ 142.80 亿元，或归母净利润（剔 除股份支付费用后）分别不低于 16.80/ 18.80/ 22.80/ 26.80 亿元。 点评： 本次授予股票数量、激励人数远高于上一期，有助于调动高管和核心骨 干人员积极性，并且指引 2027-2029 年收入同比增速分别为 9.1%/ 8.1%/ 7.5%，或净利润增速为 11.9%/ 21.3%/ 17.5%，彰显公司对未来发 展信心。 手套价格逐步企稳，公司在手订单充足。2025 年 1 月以来， ...